Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGP-437 vs Prednisolone Acetate in Anterior Uveitis
NCT02517619Phase 3Completed
- Sponsor
- Kiora Pharmaceuticals
- Start
- Jan 2016
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone phosphate iontophoretic ophthalmic solution in anterior uveitis (AU), sponsored by Kiora Pharmaceuticals. Started Jan 2016; status: completed.
02
Drugs
dexamethasone phosphate iontophoretic ophthalmic solution
03
Conditions
anterior uveitis (AU)
Beyond the preview
Go deeper on NCT02517619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517619.